Roy Chin, a former executive medical device executive based in Pleasanton, has launched three health-care start-ups of his own, he tells VentureWire (sub required).
The companies are Nanovasc, focusing on vascular regeneration; Nanonerve Inc., with a concentration on neural regeneration products; and Spine View Inc., which is developing percutaneous tools for spinal surgery to replace more invasive procedures. The companies are all formed from technology licenses secured from Stanford University and the University of California at Berkley, Chin told VentureWire.
Two of the companies have similar underlying technology. “Nanovasc is a nanotechnology company with a proprietary compound that can regenerate new blood vessels and has a biodegradable stent,” he said. “Nanonerve is similar to Nanovasc, but it’s for nerve regeneration. The third company, Spine View, is developing percutaneous tools for spinal surgery to replace more invasive procedures, Chin said.
From the tone of the story, he is apparently trying to sell these companies or get money from investors.